OXYTOCIN INHIBITS PROLIFERATION OF HUMAN BREAST-CANCER CELL-LINES

被引：0
|
作者：
CASSONI, P [1 ]
SAPINO, A [1 ]
NEGRO, F [1 ]
BUSSOLATI, G [1 ]
机构：
[1] UNIV TURIN, DEPT BIOMED SCI & ONCOL, I-10126 TURIN, ITALY
来源：
VIRCHOWS ARCHIV | 1994年 / 425卷 / 05期
关键词：
OXYTOCIN; BREAST CANCER; CELL GROWTH;
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
In this study we show that treatment of MDA-MB231 hormone-independent human breast cancer cells with oxytocin (OT) or with the OT analogue F314 induces significant growth inhibition together with a change in cell phenotype. In MCF7 and T47D human breast cancer cells, OT inhibits oestrogen-induced cell growth. In these same cells, OT administration significantly enhances the inhibitory effect of tamoxifen on cell proliferation. MDA-MB231, MCF7 and T47D cells all express mRNA specific for the OT receptor. These data suggest that it may be possible to inhibit breast cancer growth using OT and OT analogues.
引用
收藏
页码：467 / 472
页数：6
相关论文
共 50 条
  • [1] DIFFERENTIATION STATE AND INVASIVENESS OF HUMAN BREAST-CANCER CELL-LINES
    SOMMERS, CL
    BYERS, SW
    THOMPSON, EW
    TORRI, JA
    GELMANN, EP
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 31 (2-3) : 325 - 335
  • [2] CONTROL OF THE EXPRESSION OF THROMBOSPONDIN-1 IN HUMAN BREAST-CANCER CELL-LINES
    MICHAUD, M
    POYET, P
    ANTICANCER RESEARCH, 1994, 14 (3A) : 1127 - 1131
  • [3] Knockdown of PAICS inhibits malignant proliferation of human breast cancer cell lines
    Meng, Minjun
    Chen, Yanling
    Jia, Jianbo
    Li, Lianghui
    Yang, Sumei
    BIOLOGICAL RESEARCH, 2018, 51
  • [4] REGULATION OF P53 PROTEIN EXPRESSION IN HUMAN BREAST-CANCER CELL-LINES
    VOJTESEK, B
    LANE, DP
    JOURNAL OF CELL SCIENCE, 1993, 105 : 607 - 612
  • [5] Knockdown of PAICS inhibits malignant proliferation of human breast cancer cell lines
    Minjun Meng
    Yanling Chen
    Jianbo Jia
    Lianghui Li
    Sumei Yang
    Biological Research, 51
  • [6] CHARACTERIZATION OF A H-3 GNRH METHOD FOR THE MEASUREMENT OF GNRH BINDING-SITES IN HUMAN BREAST-CANCER AND BREAST-CANCER CELL-LINES
    RESHKIN, SJ
    PEZZETTA, A
    ALBARANI, V
    SCHITTULLI, F
    PARADISO, A
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 7 (02) : 371 - 375
  • [7] COMPARATIVE CHEMOSENSITIVITY PROFILES IN 3 HUMAN BREAST-CANCER CELL-LINES WITH THE ATP-CELL VIABILITY ASSAY
    KOECHLI, OR
    SEVIN, BU
    PERRAS, JP
    ANGIOLI, R
    UNTCH, M
    STEREN, A
    RAMACHANDRAN, C
    AVERETTE, HE
    ONCOLOGY, 1994, 51 (06) : 552 - 558
  • [8] EFFECTS OF TOREMIFENE AND ITS MAIN METABOLITES ON GROWTH OF BREAST-CANCER CELL-LINES
    CORADINI, D
    BIFFI, A
    CAPPELLETTI, V
    DIFRONZO, G
    ANTICANCER RESEARCH, 1991, 11 (06) : 2191 - 2197
  • [9] ESTROGENS, PROTEASES AND BREAST-CANCER - FROM CELL-LINES TO CLINICAL-APPLICATIONS
    ROCHEFORT, H
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (10) : 1583 - 1586
  • [10] INVITRO POTENTIATION BY LONIDAMINE OF THE CYTOTOXIC EFFECT OF ADRIAMYCIN ON PRIMARY AND ESTABLISHED BREAST-CANCER CELL-LINES
    SAVINI, S
    ZOLI, W
    NANNI, O
    VOLPI, A
    FRASSINETI, GL
    MAGNI, E
    FLAMIGNI, A
    AMADORI, A
    AMADORI, D
    BREAST CANCER RESEARCH AND TREATMENT, 1992, 24 (01) : 27 - 34
12345